Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.35 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.33 |
| ▸ | GPR84 | Q9NQS5 | 4/20 | 0.32 |
| ▸ | FOLH1 | Q04609 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.31 |
| ▸ | AKR1A1 | P14550 | 1/20 | 0.31 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.31 |
| ▸ | HTR2A | P28223 | 1/20 | 0.31 |
| ▸ | HTR2C | P28335 | 1/20 | 0.31 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.31 |
| ▸ | HRH1 | P35367 | 1/20 | 0.31 |
| ▸ | DRD3 | P35462 | 1/20 | 0.31 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.31 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8407151 | 1.00 | TDP1 (0.39) | TDP1SMN1; SMN2SLC22A6FFAR3GPR84 | |
| SCHEMBL5596062 | 0.83 | ECE1 (0.31) | — | |
| SCHEMBL27670709 | 0.83 | ECE1 (0.31) | — | |
| SCHEMBL3728136 | 0.81 | CHRM1 (0.33) | TDP1FFAR3CHRM1AKR1A1CHRM3 | |
| SCHEMBL11269612 | 0.79 | TDP1 (0.40) | TDP1SMN1; SMN2SLC22A6FFAR3GPR84 | |
| SCHEMBL1172848 | 0.79 | TDP1 (0.40) | TDP1SMN1; SMN2SLC22A6FFAR3GPR84 | |
| SCHEMBL13100502 | 0.79 | TDP1 (0.40) | TDP1SMN1; SMN2SLC22A6FFAR3GPR84 | |
| SCHEMBL7701636 | 0.78 | CYP1A2 (0.45) | FFAR3FOLH1HDAC1HDAC2 | |
| SCHEMBL4655463 | 0.78 | CYP1A2 (0.45) | FFAR3FOLH1HDAC1HDAC2 | |
| Hydrochloric Acid SCHEMBL3425583 | 0.77 | TDP1 (0.39) | TDP1SMN1; SMN2SLC22A6FFAR3GPR84 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090221471-A1 | PRODRUGS OF VANCOMYCIN WITH HYDROLYSIS RESISTANT POLYMER LINKAGES | ENZON PHARMACEUTICALS, INC. (US) | 2009-09-03 | — | — | US | disclosed |
| US-7462687-B2 | Prodrugs of vancomycin with hydrolysis resistant polymer linkages | ENZON PHARMACEUTICALS, INC. (US) | 2008-12-09 | — | — | US | disclosed |
| US-20040142858-A1 | Prodrugs of vancomycin with hydrolysis resistant polymer linkages | BELROSE PHARMA INC. | 2004-07-22 | — | — | US | disclosed |
| WO-2004044223-A2 | PRODRUGS OF VANCOMYCIN WITH HYDROLYSIS RESISTANT POLYMER LINKERS | ENZON PHARMACEUTICALS, INC. (US) | 2004-05-27 | — | — | WO | disclosed |
| EP-0770057-B1 | METHOD FOR PRODUCING CALCIUM SALTS OF [S,S]-ETHYLENEDIAMINE-N,N'-DISUCCINIC ACID | ALBEMARLE CORP (US) | 1999-07-14 | — | — | EP | disclosed |
| EP-0770057-A1 | METHOD FOR PRODUCING CALCIUM SALTS OF [S,S]-ETHYLENEDIAMINE-N,N'-DISUCCINIC ACID | ALBEMARLE CORPORATION (US) | 1997-05-02 | — | — | EP | disclosed |
| US-5550285-A | Method for producing calcium salts of [S,S]-ethylenediamine-N,N'-disuccinic acid | ALBEMARLE CORPORATION | 1996-08-27 | — | — | US | disclosed |
| WO-1996001804-A1 | METHOD FOR PRODUCING CALCIUM SALTS OF [S,S]-ETHYLENEDIAMINE-N,N'-DISUCCINIC ACID | ALBEMARLE CORPORATION (US) | 1996-01-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040142858-A1 | Prodrugs of vancomycin with hydrolysis resistant polymer linkages | SI, DNPEP, PEPD | TDP1 1472/4885SMN1; SMN2 3619/4885SLC22A6 1602/4885 |
| US-20090221471-A1 | PRODRUGS OF VANCOMYCIN WITH HYDROLYSIS RESISTANT POLYMER LINKAGES | SI, DNPEP, PEPD | TDP1 1472/4885SMN1; SMN2 3619/4885SLC22A6 1602/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.